Tomorrow marks the 165th anniversary of Rabindranath Tagore's birthday. We remember the poet by sharing one of his most famous poems, "Gitanjali 35".
Stay tuned to learn more about Tagore tomorrow.
Read our latest article: https://t.co/THJ8XPlUqw
TAVR patients with T2DM/obesity, GLP-1 RA use was associated with:
↓ MACE
↓ Mortality
↓ AMI and Stroke
↓ HF exacerbations
↓ AF/flutter
Large TriNetX analysis at 1 year follow up (2020–2025). #CardioTwitter#TAVR
LDL-C is the beginning of prevention, not the end.
A patient with established CAD and LDL-C of 48 mg/dL may still be biologically high-risk.
Welcome to residual risk—the next frontier in secondary prevention. 🧵
I sat down with my mentor Dr. Eugene Braunwald for a 3 part series about his life.
In part 1 we talk about his early years:
"Everything changed on March 12, 1938 when Hitler marched in with the Nazis & my father was arrested"
Hear how they escaped here
For better video quality view here: https://t.co/1l3DhounN4
The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology.
Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association��supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish.
https://t.co/ieZuHYMyOP
Dr. Howard Tucker has been awarded the record title for the oldest doctor ever after working until the age of 103.
He was continuing to work as a neurologist until just two months before his passing on 22 December 2025.
The #SGLTi have likely accrued the most indications of any class across biomedicine in recent regulatory history
FDA approval for 6 drugs
✅ Glycemic control in T2D (5)
✅ CV risk reduction in T2D (3)
✅ HF irrespective of LVEF (3)
✅ CKD with or without T2D (2)
✅ CKD & T2D (2)
@BerglundMd @Verma1Beni @mdyesilyaprak@GaurangaMD
📌 largest cohort study for post cardiac injury syndrome related recurrent pericarditis
🚨Female gender, steroid use, number of prior recurrences associated with less clinical remission